YD Bio Limited Warrants
NASDAQ: YDESW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ethan Shen
- Employees
- 4
- Headquarters
- Taipei, Taiwan
- IPO year
- 2025
- Market cap
- $861.5K
- Website
- https://www.ydesgroup.com
Loading YDESW…
Loading profile data…Frequently asked questions about YDESW
What does YD Bio Limited Warrants (YDESW) do?
YD Bio Limited specializes in pioneering diagnostic and therapeutic technologies. Its offerings encompass oncology screening solutions, regenerative treatments for ophthalmology, and advancements in exosome research. Established on February 6, 2024, the firm is based in Taipei, Taiwan.
Where does YDESW trade?
YD Bio Limited Warrants (YDESW) trades on the NASDAQ Global Select.
What sector is YDESW in?
YD Bio Limited Warrants (YDESW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of YD Bio Limited Warrants?
Ethan Shen is the chief executive officer of YD Bio Limited Warrants (YDESW).
Where is YD Bio Limited Warrants headquartered?
YD Bio Limited Warrants is headquartered in Taiwan.
Does YDESW pay a dividend?
YD Bio Limited Warrants (YDESW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did YDESW go public?
YD Bio Limited Warrants (YDESW) completed its initial public offering in 2025.